Screener
Kestra Medical Technologies KMTS Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Kestra Medical Technologies in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: Kestra Medical Technologies’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 5:16 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001193125-26-303397
| Line item | Year Ended April 30, 2026 | Year Ended April 30, 2025 |
|---|---|---|
| Total operating expenses | 183,604 | 130,588 |
| Loss from operations | (134,741) | (106,378) |
| Other expense (income): | ||
| Interest expense | 7,546 | 7,734 |
| Interest income | (8,351) | (3,199) |
| Other expense (income) | (2,618) | 2,766 |
| Net loss before provision for income taxes | (131,318) | (113,679) |
| Provision for income taxes | 294 | 135 |
Item 16. Form 10-K Summary.
FAQ
- What is Kestra Medical Technologies's interest expense?
- Kestra Medical Technologies (KMTS) reported interest expense of $1.84M in Q1 2026.
- How has Kestra Medical Technologies's interest expense changed year-over-year?
- Kestra Medical Technologies's interest expense increased by 4.8% year-over-year, from $1.76M to $1.84M.
- What is the long-term trend for Kestra Medical Technologies's interest expense?
- Over 2 years (2024 to 2026), Kestra Medical Technologies's interest expense has grown at a 10.0% compound annual growth rate (CAGR), from $6.23M to $7.55M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about Kestra Medical Technologies's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude